Clinical Trial Update: Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update evaluates the safety and efficacy of busulfan as a conditioning regimen prior to hematopoietic cell transplantation, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Myelodysplastic Syndromes, Myeloproliferative Disorders | Phase 4 | Status: COMPLETED | Results posted: 2013-06-27